Voltaren vs Mobic
A side-by-side look at two pain relief medications advertised on TV. Informational only — not medical advice.
| NZ Voltaren | NZ Mobic | |
|---|---|---|
| Generic name | diclofenac | meloxicam |
| Drug class | NSAID (Non-Steroidal Anti-Inflammatory Drug) | NSAID |
| Treats | Arthritis, muscle pain, joint pain | Arthritis, joint inflammation |
| Category | Pain Relief | Pain Relief |
| Manufacturer | Haleon | Boehringer Ingelheim |
| Year approved | 1988 | 2001 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $12M | $1M |
| Common side effects | Stomach upset, Heartburn, Skin irritation (topical), Increased blood pressure | Stomach upset, Heartburn, Increased blood pressure, Kidney problems |
Frequently asked questions
Is Voltaren or Mobic better?
Neither is universally "better." Voltaren (diclofenac) and Mobic (meloxicam) are both used for pain relief, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Voltaren and Mobic?
Voltaren is a NSAID (Non-Steroidal Anti-Inflammatory Drug) made by Haleon, while Mobic is a NSAID made by Boehringer Ingelheim. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Voltaren has the larger estimated TV advertising budget of the two.